Keratin 17 (KRT17) (C-Term) Peptide
KRT17
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5512234
Aperçu rapide pour Keratin 17 (KRT17) (C-Term) Peptide (ABIN5512234)
Antigène
KRT17
(Keratin 17 (KRT17))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Séquence
- EMDAAPGVDL SRILNEMRDQ YEKMAEKNRK DAEDWFFSKT EELNREVATN
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-KRT17 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- KRT17 (Keratin 17 (KRT17))
-
Sujet
-
This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
Alias Symbols: KRT17,
Protein Size: 432 -
ID gène
- 3872
-
NCBI Accession
- NP_000413
-
UniProt
- Q04695
Antigène
-
Vous êtes ici:
